Onychomycosis Treatment Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Onychomycosis Treatment Market
Onychomycosis Treatment Market: By Product Type (Tablet, Nail Paint, Device –Laser Beam and Ultra Sound) & By Geography (Europe, Asia Pacific, North America, Rest of the World) - Forecast(2018 - 2023)
Report Code : HCR 0328
Updated Date: 16 May, 2018  

1. Onychomycosis Treatment – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Onychomycosis Treatment – Market Forces
   4.1. Drivers
      4.1.1. Increased prevalence rate of diabetic patients and geriatric population.
      4.1.2. Consistent rise in the prevalence of onychomycosis infections
      4.1.3. Development of novel medications
   4.2. Restrains
      4.2.1. Increased circulation of off label products
      4.2.2. Negligence towards this infection especially in less developed economies
   4.3. Opportunities
      4.3.1 Emerging Economies
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Onychomycosis Treatment – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Onychomycosis Treatment Market, By Product Type
   6.1. Tablet
   6.2. Nail Paint
   6.3. Device –Laser Beam and Ultra Sound Migraines
   6.4. Others
7. Onychomycosis Treatment Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Onychomycosis Treatment – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   9.1. GlaxoSmithKline Pharmaceuticals Limited
   9.2. Pfizer Inc.
   9.3. Abbott Laboratories
   9.4. Galaderma
   9.5. Janssen Global Services, LLC
   9.6. NuvoLase, Inc
   9.7. Cutera
   9.8. Sciton Inc,
   9.9. Novartis AG
   9.10. Bristol Meyer Squibb
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix

   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation of expert Insights
   10.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll